Aphrodite Health is the first female-focused and founded psychedelic medicine biotech company.
Aphrodite aims to elevate women’s health and autonomy by developing targeted psychedelic therapeutics for women with chronic pain and hormone-related mood disorders including premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD).
“Psychedelic medicine for women, by women.”
- First Female-founded Psychedelic Biotech Company Launches (Businesswire, June 2021)
- Aphrodite Health Is Here To Shift The Narrative: The First Psychedelics Company ‘For Women, By Women’ (Forbes, June 2021)
B2B B2C Biotech
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates